Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021
Abstract Objective To examine the burden of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region from 1990 to 2021 by age and sociodemographic index (SDI). Methods Data were sourced from the Global Burden of Disease (GBD) 2021 database. We analysed the incidence, prev...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-025-21735-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861490219745280 |
|---|---|
| author | Saeid Safiri Fikrettin Şahin Reza Aletaha Mark J. M. Sullman Reza Shekarriz-Foumani Ali-Asghar Kolahi |
| author_facet | Saeid Safiri Fikrettin Şahin Reza Aletaha Mark J. M. Sullman Reza Shekarriz-Foumani Ali-Asghar Kolahi |
| author_sort | Saeid Safiri |
| collection | DOAJ |
| description | Abstract Objective To examine the burden of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region from 1990 to 2021 by age and sociodemographic index (SDI). Methods Data were sourced from the Global Burden of Disease (GBD) 2021 database. We analysed the incidence, prevalence, and years lived with disability (YLDs) attributable to BPH across the MENA region and its constituent countries. Results In 2021, the MENA region had an estimated 4.7 million prevalent cases of BPH, with an age-standardised prevalence rate of 2168.6 per 100,000. BPH contributed to 93.6 thousand YLDs, with an age-standardised YLD rate of 42.8 per 100,000. The highest prevalence and incidence rates were observed in Jordan, Qatar, and Iran, while Egypt and Yemen recorded the lowest rates. The burden of BPH was found to increase with age, peaking in the 65–69 age range. Conclusion This study reveals an increasing burden of BPH in the MENA region, primarily due to aging populations. These findings underscore the need for tailored public health policies and strategies to enhance early detection, prevention, and management of BPH, thereby reducing its impact on healthcare systems and individuals. |
| format | Article |
| id | doaj-art-a695d0f6dc3f4957affc27a8e92e1340 |
| institution | Kabale University |
| issn | 1471-2458 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj-art-a695d0f6dc3f4957affc27a8e92e13402025-02-09T12:58:42ZengBMCBMC Public Health1471-24582025-02-0125111210.1186/s12889-025-21735-2Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021Saeid Safiri0Fikrettin Şahin1Reza Aletaha2Mark J. M. Sullman3Reza Shekarriz-Foumani4Ali-Asghar Kolahi5Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical SciencesDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe UniversitySocial Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical SciencesDepartment of Life and Health Sciences, University of NicosiaSocial Determinants of Health Research Center, Shahid Beheshti University of Medical SciencesSocial Determinants of Health Research Center, Shahid Beheshti University of Medical SciencesAbstract Objective To examine the burden of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region from 1990 to 2021 by age and sociodemographic index (SDI). Methods Data were sourced from the Global Burden of Disease (GBD) 2021 database. We analysed the incidence, prevalence, and years lived with disability (YLDs) attributable to BPH across the MENA region and its constituent countries. Results In 2021, the MENA region had an estimated 4.7 million prevalent cases of BPH, with an age-standardised prevalence rate of 2168.6 per 100,000. BPH contributed to 93.6 thousand YLDs, with an age-standardised YLD rate of 42.8 per 100,000. The highest prevalence and incidence rates were observed in Jordan, Qatar, and Iran, while Egypt and Yemen recorded the lowest rates. The burden of BPH was found to increase with age, peaking in the 65–69 age range. Conclusion This study reveals an increasing burden of BPH in the MENA region, primarily due to aging populations. These findings underscore the need for tailored public health policies and strategies to enhance early detection, prevention, and management of BPH, thereby reducing its impact on healthcare systems and individuals.https://doi.org/10.1186/s12889-025-21735-2Benign prostatic hyperplasiaMiddle East and North AfricaGlobal Burden of DiseasePrevalenceIncidence |
| spellingShingle | Saeid Safiri Fikrettin Şahin Reza Aletaha Mark J. M. Sullman Reza Shekarriz-Foumani Ali-Asghar Kolahi Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 BMC Public Health Benign prostatic hyperplasia Middle East and North Africa Global Burden of Disease Prevalence Incidence |
| title | Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 |
| title_full | Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 |
| title_fullStr | Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 |
| title_full_unstemmed | Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 |
| title_short | Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021 |
| title_sort | burden of benign prostatic hyperplasia in the middle east and north africa region 1990 2021 |
| topic | Benign prostatic hyperplasia Middle East and North Africa Global Burden of Disease Prevalence Incidence |
| url | https://doi.org/10.1186/s12889-025-21735-2 |
| work_keys_str_mv | AT saeidsafiri burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 AT fikrettinsahin burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 AT rezaaletaha burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 AT markjmsullman burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 AT rezashekarrizfoumani burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 AT aliasgharkolahi burdenofbenignprostatichyperplasiainthemiddleeastandnorthafricaregion19902021 |